Asia Pacific AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025

List of Tables

The Asia Pacific AI In Drug Repurposing Market would witness market growth of 20.5% CAGR during the forecast period (2025-2032).

The China market dominated the Asia Pacific AI In Drug Repurposing Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $310.2 million by 2032. The Japan market is registering a CAGR of 19.7% during (2025 - 2032). Additionally, The India market would showcase a CAGR of 21.3% during (2025 - 2032). The China and Japan led the Asia Pacific AI In Drug Repurposing Market by Country with a market share of 38.4% and 18.4% in 2024. The Malaysia market is expected to witness a CAGR of 24.5% during throughout the forecast period.

The Asia Pacific AI-driven drug repurposing industry has grown quickly along with the region's growing biotechnology, genomics, and digital health infrastructure. At first, the field was disorganized and mostly academic. But it has grown thanks to improvements in cloud computing, biomedical databases, and government support in China, India, Japan, South Korea, and Southeast Asia. Today, local biotech companies combine AI with clinical and pharmacological data, thanks to government programs that encourage the use of AI in biotech. Asia Pacific has gone from being a user of AI repurposing technologies to a producer of cutting-edge, regionally tailored platforms thanks to strategic partnerships with hospitals, innovation agencies, and global pharmaceutical companies.

This growth is driven by three main trends: a focus on diseases that have been ignored or are specific to certain areas, the use of federated modeling to get around data privacy issues, and a rise in cross-border partnerships for validation and commercialization. Companies stay competitive by vertically integrating with health systems, focusing on specific therapeutic areas in their region, and working with pharmaceutical companies to develop new drugs or license existing ones. Even though competition isn't the same in all countries, the market is coming together around companies with strong AI knowledge, local clinical integration, and regulatory compliance. This shows a shift from algorithmic innovation to trust, explainability, and deep embedding in the healthcare ecosystem.

Technology Outlook

Based on Technology, the market is segmented into Machine Learning/Deep Learning, Natural Language Processing (NLP), Knowledge Graphs & Network-Based AI, Generative AI & Large Language Models (LLMs), and Computer Vision. The Machine Learning/Deep Learning market segment dominated the China AI In Drug Repurposing Market by Technology is expected to grow at a CAGR of 17.7 % during the forecast period thereby continuing its dominance until 2032. Also, The Computer Vision market is anticipated to grow as a CAGR of 23.3 % during the forecast period during (2025 - 2032).

Application Outlook

Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Rare & Orphan Diseases, Cardiology, and Other Application. Among various Singapore AI In Drug Repurposing Market by Application; The Oncology market achieved a market size of USD $3.7 Million in 2024 and is expected to grow at a CAGR of 21.1 % during the forecast period. The Cardiology market is predicted to experience a CAGR of 23.8% throughout the forecast period from (2025 - 2032).

Country Outlook

China is quickly becoming a major center for AI-driven drug repurposing. This is thanks to strong government programs like Healthy China 2030 and Made in China 2025, a lot of healthcare data, and more biotech innovation. The country's large electronic health records, genomic data, and high-performance computing infrastructure make it possible to do large-scale AI modeling. Startups in the country and partnerships with companies around the world make the country more competitive. AI platforms use multi-omics and real-world evidence to speed up drug translation in areas like oncology, cardiovascular, metabolic, and infectious diseases. China's size, funding ecosystem, and changing policy landscape make it well-positioned to lead AI-enabled drug repurposing across the Asia Pacific, even though data governance, interoperability, and regulatory adaptation are still problems.

List of Key Companies Profiled

Ginkgo Bioworks Holdings, Inc.
IBM Corporation
Atomwise, Inc.
Cyclica, Inc.
Genesis Healthcare Co.
Verge, Inc.
Novartis AG
Schrodinger, Inc
Recursion Pharmaceuticals, Inc.
The Cradle Company

Asia Pacific AI In Drug Repurposing Market Report Segmentation

By Component

Software & Platform
Services

By Technology

Machine Learning/Deep Learning
Natural Language Processing (NLP)
Knowledge Graphs & Network-Based AI
Generative AI & Large Language Models (LLMs)
Computer Vision

By End Use

Pharmaceutical & BioTechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Other End Use

By Application

Oncology
Neurology
Infectious Diseases
Rare & Orphan Diseases
Cardiology
Other Application

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific AI In Drug Repurposing Market, by Component
- 1.4.2 Asia Pacific AI In Drug Repurposing Market, by Technology
- 1.4.3 Asia Pacific AI In Drug Repurposing Market, by End Use
- 1.4.4 Asia Pacific AI In Drug Repurposing Market, by Application
- 1.4.5 Asia Pacific AI In Drug Repurposing Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Market Trends - Asia Pacific AI In Drug Repurposing Market

Chapter 5. State of Competition - Asia Pacific AI In Drug Repurposing Market

Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market

Chapter 7. Product Life Cycle - AI In Drug Repurposing Market

Chapter 8. Market Consolidation - AI In Drug Repurposing Market

Chapter 9. Key Customer Criteria - AI In Drug Repurposing Market

Chapter 10. Asia Pacific AI In Drug Repurposing Market by Component

10.1 Asia Pacific Software & Platform Market by Country
10.2 Asia Pacific Services Market by Country

Chapter 11. Asia Pacific AI In Drug Repurposing Market by Technology

11.1 Asia Pacific Machine Learning/Deep Learning Market by Country
11.2 Asia Pacific Natural Language Processing (NLP) Market by Country
11.3 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country
11.4 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country
11.5 Asia Pacific Computer Vision Market by Country

Chapter 12. Asia Pacific AI In Drug Repurposing Market by End Use

12.1 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country
12.2 Asia Pacific Contract Research Organizations (CROs) Market by Country
12.3 Asia Pacific Academic & Research Institutes Market by Country
12.4 Asia Pacific Other End Use Market by Country

Chapter 13. Asia Pacific AI In Drug Repurposing Market by Application

13.1 Asia Pacific Oncology Market by Country
13.2 Asia Pacific Neurology Market by Country
13.3 Asia Pacific Infectious Diseases Market by Country
13.4 Asia Pacific Rare & Orphan Diseases Market by Country
13.5 Asia Pacific Cardiology Market by Country
13.6 Asia Pacific Other Application Market by Country

Chapter 14. Asia Pacific AI In Drug Repurposing Market by Country

14.1 China AI In Drug Repurposing Market
- 14.1.1 China AI In Drug Repurposing Market by Component
- 14.1.2 China AI In Drug Repurposing Market by Technology
- 14.1.3 China AI In Drug Repurposing Market by End Use
- 14.1.4 China AI In Drug Repurposing Market by Application
14.2 Japan AI In Drug Repurposing Market
- 14.2.1 Japan AI In Drug Repurposing Market by Component
- 14.2.2 Japan AI In Drug Repurposing Market by Technology
- 14.2.3 Japan AI In Drug Repurposing Market by End Use
- 14.2.4 Japan AI In Drug Repurposing Market by Application
14.3 India AI In Drug Repurposing Market
- 14.3.1 India AI In Drug Repurposing Market by Component
- 14.3.2 India AI In Drug Repurposing Market by Technology
- 14.3.3 India AI In Drug Repurposing Market by End Use
- 14.3.4 India AI In Drug Repurposing Market by Application
14.4 South Korea AI In Drug Repurposing Market
- 14.4.1 South Korea AI In Drug Repurposing Market by Component
- 14.4.2 South Korea AI In Drug Repurposing Market by Technology
- 14.4.3 South Korea AI In Drug Repurposing Market by End Use
- 14.4.4 South Korea AI In Drug Repurposing Market by Application
14.5 Singapore AI In Drug Repurposing Market
- 14.5.1 Singapore AI In Drug Repurposing Market by Component
- 14.5.2 Singapore AI In Drug Repurposing Market by Technology
- 14.5.3 Singapore AI In Drug Repurposing Market by End Use
- 14.5.4 Singapore AI In Drug Repurposing Market by Application
14.6 Malaysia AI In Drug Repurposing Market
- 14.6.1 Malaysia AI In Drug Repurposing Market by Component
- 14.6.2 Malaysia AI In Drug Repurposing Market by Technology
- 14.6.3 Malaysia AI In Drug Repurposing Market by End Use
- 14.6.4 Malaysia AI In Drug Repurposing Market by Application
14.7 Rest of Asia Pacific AI In Drug Repurposing Market
- 14.7.1 Rest of Asia Pacific AI In Drug Repurposing Market by Component
- 14.7.2 Rest of Asia Pacific AI In Drug Repurposing Market by Technology
- 14.7.3 Rest of Asia Pacific AI In Drug Repurposing Market by End Use
- 14.7.4 Rest of Asia Pacific AI In Drug Repurposing Market by Application

Chapter 15. Company Profiles

15.1 Ginkgo Bioworks Holdings, Inc.
- 15.1.1 Company Overview
- 15.1.2 Financial Analysis
- 15.1.3 Segmental and Regional Analysis
- 15.1.4 Research & Development Expenses
- 15.1.5 Recent strategies and developments:
  - 15.1.5.1 Partnerships, Collaborations, and Agreements:
- 15.1.6 SWOT Analysis
15.2 IBM Corporation
- 15.2.1 Company Overview
- 15.2.2 Financial Analysis
- 15.2.3 Regional & Segmental Analysis
- 15.2.4 Research & Development Expenses
- 15.2.5 Recent strategies and developments:
  - 15.2.5.1 Partnerships, Collaborations, and Agreements:
- 15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
- 15.3.1 Company Overview
15.4 Cyclica, Inc.
- 15.4.1 Company Overview
15.5 Genesis Healthcare Co.
- 15.5.1 Company Overview
15.6 Verge, Inc.
- 15.6.1 Company Overview
15.7 Novartis AG
- 15.7.1 Company Overview
- 15.7.2 Financial Analysis
- 15.7.3 Segmental and Regional Analysis
- 15.7.4 Research & Development Expenses
- 15.7.5 SWOT Analysis
15.8 Schrodinger, Inc
- 15.8.1 Company Overview
- 15.8.2 Financial Analysis
- 15.8.3 Segmental and Regional Analysis
- 15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
- 15.9.1 Company Overview
- 15.9.2 Financial Analysis
- 15.9.3 Research & Development Expenses
15.10. The Cradle Company
- 15.10.1 Company Overview

LIST OF TABLES

TABLE 1 Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 2 Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 Asia Pacific Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 7 Asia Pacific Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 8 Asia Pacific Services Market by Country, 2021 - 2024, USD Million
TABLE 9 Asia Pacific Services Market by Country, 2025 - 2032, USD Million
TABLE 10 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 Asia Pacific Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 13 Asia Pacific Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 14 Asia Pacific Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 15 Asia Pacific Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 16 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 17 Asia Pacific Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 18 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 19 Asia Pacific Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 20 Asia Pacific Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 21 Asia Pacific Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 22 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 25 Asia Pacific Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 26 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 27 Asia Pacific Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 28 Asia Pacific Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 29 Asia Pacific Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 30 Asia Pacific Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 31 Asia Pacific Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 32 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 Asia Pacific Oncology Market by Country, 2021 - 2024, USD Million
TABLE 35 Asia Pacific Oncology Market by Country, 2025 - 2032, USD Million
TABLE 36 Asia Pacific Neurology Market by Country, 2021 - 2024, USD Million
TABLE 37 Asia Pacific Neurology Market by Country, 2025 - 2032, USD Million
TABLE 38 Asia Pacific Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 39 Asia Pacific Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 40 Asia Pacific Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 41 Asia Pacific Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 42 Asia Pacific Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 43 Asia Pacific Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 44 Asia Pacific Other Application Market by Country, 2021 - 2024, USD Million
TABLE 45 Asia Pacific Other Application Market by Country, 2025 - 2032, USD Million
TABLE 46 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 47 Asia Pacific AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 48 China AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 China AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 China AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 China AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 China AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 53 China AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 54 China AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 55 China AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 56 China AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 57 China AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 58 Japan AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 59 Japan AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 60 Japan AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 61 Japan AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 62 Japan AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 63 Japan AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 64 Japan AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 65 Japan AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 66 Japan AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 67 Japan AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 68 India AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 69 India AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 70 India AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 71 India AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 72 India AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 73 India AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 74 India AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 75 India AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 76 India AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 77 India AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 78 South Korea AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 79 South Korea AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 80 South Korea AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 81 South Korea AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 82 South Korea AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 83 South Korea AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 84 South Korea AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 85 South Korea AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 86 South Korea AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 87 South Korea AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 88 Singapore AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 89 Singapore AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 90 Singapore AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 91 Singapore AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 92 Singapore AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 93 Singapore AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 94 Singapore AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 95 Singapore AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 96 Singapore AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 97 Singapore AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 98 Malaysia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 99 Malaysia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 100 Malaysia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 101 Malaysia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 102 Malaysia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 103 Malaysia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 104 Malaysia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 105 Malaysia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 106 Malaysia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 107 Malaysia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 108 Rest of Asia Pacific AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 109 Rest of Asia Pacific AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 110 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 111 Rest of Asia Pacific AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 112 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 113 Rest of Asia Pacific AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 114 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 115 Rest of Asia Pacific AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 116 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 117 Rest of Asia Pacific AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 118 Key Information - GINKGO BIOWORKS HOLDINGS, INC.
TABLE 119 Key Information - IBM Corporation
TABLE 120 Key Information - Atomwise, Inc.
TABLE 121 Key Information - Cyclica, Inc.
TABLE 122 Key Information - Genesis Healthcare Co.
TABLE 123 Key Information - Verge, Inc.
TABLE 124 Key Information - Novartis AG
TABLE 125 Key Information - Schrodinger, Inc
TABLE 126 Key Information - Recursion Pharmaceuticals, Inc.
TABLE 127 Key Information - The Cradle Company

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 Asia Pacific AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting asia pacific ai in drug repurposing Market
FIG 4 Porter's Five Forces Analysis - AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle - AI In Drug Repurposing Market
FIG 7 Market Consolidation - AI In Drug Repurposing Market
FIG 8 Key Customer Criteria - AI In Drug Repurposing Market
FIG 9 Asia Pacific AI In Drug Repurposing Market share by Component, 2024
FIG 10 Asia Pacific AI In Drug Repurposing Market share by Component, 2032
FIG 11 Asia Pacific AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 Asia Pacific AI In Drug Repurposing Market share by Technology, 2024
FIG 13 Asia Pacific AI In Drug Repurposing Market share by Technology, 2032
FIG 14 Asia Pacific AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 Asia Pacific AI In Drug Repurposing Market share by End Use, 2024
FIG 16 Asia Pacific AI In Drug Repurposing Market share by End Use, 2032
FIG 17 Asia Pacific AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 Asia Pacific AI In Drug Repurposing Market share by Application, 2024
FIG 19 Asia Pacific AI In Drug Repurposing Market share by Application, 2032
FIG 20 Asia Pacific AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 Asia Pacific AI In Drug Repurposing Market share by Country, 2024
FIG 22 Asia Pacific AI In Drug Repurposing Market share by Country, 2032
FIG 23 Asia Pacific AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 24 Swot Analysis: Ginkgo Bioworks
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: Novartis AG

Asia Pacific AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents